BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12366454)

  • 1. High-dose interferon and the U.K. guidelines for cutaneous melanoma.
    Russell-Jones R; Healy C; Calonje E; Doherty M; Acland K
    Br J Dermatol; 2002 Oct; 147(4):832-4; author reply 834-5. PubMed ID: 12366454
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of sentinel lymph node biopsy and adjuvant interferon treatment in thick (>4 mm) cutaneous melanoma: an observational study.
    Morera-Sendra N; Tejera-Vaquerizo A; Traves V; Requena C; Bolumar I; Pla A; Vázquez C; Soriano V; Nagore E
    Eur J Dermatol; 2016; 26(1):34-48. PubMed ID: 27023017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised U.K. guidelines for the management of cutaneous melanoma 2010.
    Marsden JR; Newton-Bishop JA; Burrows L; Cook M; Corrie PG; Cox NH; Gore ME; Lorigan P; MacKie R; Nathan P; Peach H; Powell B; Walker C;
    Br J Dermatol; 2010 Aug; 163(2):238-56. PubMed ID: 20608932
    [No Abstract]   [Full Text] [Related]  

  • 4. [Conclude that clinical trials on the overall effectiveness of interferon? Contribution of recent data].
    Boulinguez S; Grange F
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H21-4. PubMed ID: 21703461
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of surgery in the treatment of cutaneous melanoma].
    Guggenheim M; Dummer R; Giovanoli P
    Praxis (Bern 1994); 2011 Jul; 100(15):911-6. PubMed ID: 21792806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy and the U.K. guidelines for cutaneous melanoma.
    Phillips WG
    Br J Dermatol; 2002 Oct; 147(4):834. PubMed ID: 12366455
    [No Abstract]   [Full Text] [Related]  

  • 7. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
    McMasters KM; Edwards MJ; Ross MI; Reintgen DS; Martin RC; Urist MM; Noyes RD; Sussman JJ; Stromberg AJ; Scoggins CR
    Ann Surg; 2010 Sep; 252(3):460-5; discussion 465-6. PubMed ID: 20739846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical and adjuvant drug therapy in head and neck cutaneous melanoma].
    Hauschild A; Lischner S; Christophers E
    Laryngorhinootologie; 2000 Jul; 79(7):428-33. PubMed ID: 11005097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant interferon in melanoma - a resurrection?
    Middleton MR; Thatcher N
    Br J Cancer; 2001 May; 84(9):1141-2. PubMed ID: 11336461
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon (IFN) for malignant melanoma unmasking an autoimmune hepatitis.
    Lebiedz P; August C; Domschke W; Schmidt HH
    Eur J Intern Med; 2009 Jan; 20(1):e3-4. PubMed ID: 19237078
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adjuvant interferon treatment of melanoma].
    Török L
    Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current therapy of carcinoma of the skin].
    Dummer R; Goldinger SM; Sailer E; French LE
    Ther Umsch; 2010 Sep; 67(9):447-52. PubMed ID: 20806173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
    McMasters KM; Egger ME; Edwards MJ; Ross MI; Reintgen DS; Noyes RD; Martin RC; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Sussman JJ; Davidson BS; Gershenwald JE; Hagendoorn LJ; Stromberg AJ; Scoggins CR
    J Clin Oncol; 2016 Apr; 34(10):1079-86. PubMed ID: 26858331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous head and neck melanoma: the old and the new.
    Rigual NR; Popat SR; Jayaprakash V; Jaggernauth W; Wong M
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):403-12. PubMed ID: 18366288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy of melanoma.
    Geskin L; Brown CR; Kirkwood JM
    Semin Cutan Med Surg; 2003 Mar; 22(1):55-67. PubMed ID: 12773014
    [No Abstract]   [Full Text] [Related]  

  • 16. Melanoma in children and the use of sentinel lymph node biopsy.
    Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
    J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How melanoma is treated in real life.
    Dummer R; Schadendorf D
    Arch Dermatol; 2008 May; 144(5):664-5. PubMed ID: 18490596
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of sentinel lymph node biopsy for thin melanoma.
    Joyce KM; McInerney NM; Joyce CW; Jones DM; Hussey AJ; Donnellan P; Kerin MJ; Kelly JL; Regan PJ
    Ir J Med Sci; 2015 Mar; 184(1):119-23. PubMed ID: 25366817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma.
    Dummer R; Siano M; Hunger RE; Lindenblatt N; Braun R; Michielin O; Mihic-Probst D; von Moos R; Najafi Y; Guckenberger M; Arnold A
    Swiss Med Wkly; 2016; 146():w14279. PubMed ID: 26901103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
    Kimyai-Asadi A; Usman A
    J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.